generic-drug

Teva acquired a 57% stake in Japanese generic-drug maker Taiyo for $460 million in cash.

What's News 2011

Israel's Teva acquired a 57% stake in Japanese generic-drug maker Taiyo for $460 million in cash.

What's News— 2011

Food and Drug Administration Commissioner Margaret Hamburg backed the idea of generic-drug companies paying fees to the agency to help relieve a backlog of applications, saying an overhaul of the current system is "critical."

FDA Chief Seeks to Speed Generics Approvals Thomas Gryta 2011

Pfizer Drug Giant to Buy Stake in Brazilian Generics Maker Pfizer Inc. will pay 400 million Brazilian reals ($238 million) for a 40% stake in Brazilian generic-drug maker Laboratorio Teuto Brasiliero and has the option to buy the rest of the company starting in 2014 as its acquisition streak continues.

Corporate Watch 2010

Pharmaceuticals Pfizer will pay 400 million Brazilian reals ($240 million) for a 40% stake in Brazilian generic-drug maker Laboratorio Teuto Brasiliero and has the option to buy the rest of the company starting in 2014 as its acquisition streak continues.

Business Watch 2010

Still, the company cautioned that this forecast is ambitious due to the strong euro and rising generic-drug competition.

Chemicals Recovery Aids Bayer Natascha Divac 2010

This week, Pfizer Inc. agreed to pay $238 million for a 40% stake in a generic-drug maker in Brazil and took an option to buy the rest of the company.

Companies Get Earnings Boost From Latin America James R. Hagerty 2010

Food and Drug Administration is going to work for the world 's largest generic-drug maker, Teva Pharmaceutical Industries Ltd.

Teva Hires Former Senior FDA Official Alicia Mundy 2010

Pfizer Inc. will pay 400 million Brazilian reals ($240 million) for a 40% stake in Brazilian generic-drug maker Laboratorio Teuto Brasiliero and has the option to buy the rest of the company starting in 2014 as its acquisition streak continues.

Pfizer to Buy 40% Stake in Brazilian Drug Firm Kevin Kingsbury 2010

Food and Drug Administration is going to work for the world 's largest generic-drug maker, Teva Pharmaceutical Industries.

Business Watch 2010